Interferon-γ for respiratory diseases [20]

Lancet

Volumn 350, Issue 9076, 1997, Pages 524-

  Smith Jones, P M ^a   Linkesch, W ^a   Virgolini, I ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON;

BACTERIAL GROWTH; CELL STIMULATION; CLINICAL TRIAL; DOSE RESPONSE; DRUG CLEARANCE; DRUG COST; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; LETTER; LUNG ALVEOLUS MACROPHAGE; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NORMAL HUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SCINTIGRAPHY;

EID: 17644441273     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63124-8     Document Type: Letter

References (5)

1. R Condos Rom WN Schluger NW Treatment of multidrug-resistant pulmonary tuberculosis with interferon-γ via aerosol Lancet 349 1997 1513 1515
2. G Chatte G Panteix M Perrin-Fayolle Y Pacheco Aerosolized interferon gamma for mycobacterium avium complex lung disease Am J Respir Crit Care Med 152 1995 1094 1096
3. RJ Martin M Boguniewicz JE Henson The effects of inhaled interferon gamma in the normal human airways Am Rev Respir Dis 148 1993 1677 1682
4. CM Black JR Catterall JS Remington In vivo and in vitro activation of alveolar macrophages by recombinant interferon-γ J Immunol 138 1987 491 495
5. 123I-labelled interferon gamma-lb: pulmonary deposition and dose escalation study in healthy volunteers. J Nucl Med (in press)..